Circulating biomarkers as surrogates for bloodstream infections
- 30 November 2007
- journal article
- review article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 30, 16-23
- https://doi.org/10.1016/j.ijantimicag.2007.06.032
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Serum Procalcitonin for Discrimination of Blood Contamination from Bloodstream Infection due to Coagulase-Negative StaphylococciInfection, 2007
- Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trialBMC Health Services Research, 2007
- Antibiotic Treatment of Exacerbations of COPDChest, 2007
- Limits to the use of the procalcitonin level as a diagnostic marker.Clinical Infectious Diseases, 2004
- New developments in the diagnosis of bloodstream infectionsThe Lancet Infectious Diseases, 2004
- Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropeniaCancer, 2004
- 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions ConferenceIntensive Care Medicine, 2003
- Assessment of Procalcitonin as a Diagnostic Marker of Underlying Infection in Patients with Febrile NeutropeniaClinical Infectious Diseases, 2001
- Endotoxin, Cytokines, and Procalcitonin in Febrile Patients Admitted to the Hospital: Identification of Subjects at High Risk of MortalityClinical Infectious Diseases, 2000
- Calcitonin precursors are reliable markers of sepsis in a medical intensive care unitCritical Care Medicine, 2000